Regeneron Pharmaceuticals (REGN) CFO exercises stock options
Rhea-AI Filing Summary
REGENERON PHARMACEUTICALS, INC. (REGN) reported that EVP Finance and CFO Christopher R. Fenimore exercised a non-qualified stock option for 6,283 shares of common stock on 2026-08-18 at an exercise price of $381.92 per share. The stock option award vested in four equal annual installments. In connection with the exercise, 4,599 shares of common stock were delivered or withheld at $813.47 per share for payment of the exercise price or tax liability. Following the transaction, Fenimore had 6,000 stock options remaining from this grant and held additional shares indirectly through a 401(k) plan and several trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,684 shares
Net Buy
7 txns
Insider
Fenimore Christopher R.
Role
EVP Finance CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F2 | 6,283 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,283 | $381.92 | $2.40M |
| Exercise Price or Tax Liability | Common Stock | 4,599 | $813.47 | $3.74M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 6,000 shares (Direct);
Common Stock — 19,984 shares (Direct);
Common Stock — 1,574 shares (Indirect, By 401(k) Plan);
Common Stock — 1,897 shares (Indirect, By Trust);
Common Stock — 25 shares (Indirect, by Trust for Daugh);
Common Stock — 25 shares (Indirect, by Trust for Son)
Footnotes (2)
- F1. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- F2. The stock option award vested in four equal annual installments, commencing one year after the date of grant.
Key Figures
Options exercised: 6,283 shares
Option exercise price: $381.92 per share
Shares delivered/withheld for exercise price or tax liability: 4,599 shares
+5 more
8 metrics
Options exercised
6,283 shares
Non-qualified stock option exercise on 2026-08-18
Option exercise price
$381.92 per share
Exercise price of non-qualified stock option
Shares delivered/withheld for exercise price or tax liability
4,599 shares
Code F transaction on 2026-08-18 at $813.47 per share
Share price used for tax/exercise withholding
$813.47 per share
Price for shares delivered or withheld under code F
Remaining options from this award
6,000 options
Non-qualified stock options following exercise, expiring 2026-12-16
Indirect shares by 401(k) plan
1,574 shares
Indirect ownership reported as of 2026-08-18
Indirect shares by spouse’s trust
1,897 shares
Held in a trust for benefit of spouse
Indirect shares by children’s trusts
25 shares each
Two trusts, one for a daughter and one for a son
Key Terms
Non-Qualified Stock Option, exercise or conversion of derivative security, Payment of exercise price or tax liability, indirect ownership, +1 more
5 terms
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option (right to buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
Payment of exercise price or tax liability financial
"transaction_code_description: "Payment of exercise price or tax liability by delivering or withholding""
indirect ownership financial
"ownership_type: "indirect" with nature of ownership by 401(k) plan and trusts"
trust financial
"These shares are held in a trust for the benefit of the reporting person's spouse"
A trust is a legal setup in which one party (the trustee) holds and manages assets—like cash, stocks or property—on behalf of other people (beneficiaries) according to instructions from the person who created it (the grantor). Think of it as a locked box with a keyholder who must follow written rules; for investors it matters because trusts influence who controls and benefits from assets, affect taxes and succession, and can change how quickly or transparently shares are bought, sold or voted.
FAQ
What did REGN executive Christopher R. Fenimore report in this Form 4?
Christopher R. Fenimore, EVP Finance and CFO of REGN, reported exercising a non-qualified stock option for 6,283 shares of common stock on 2026-08-18 and a related disposition of 4,599 shares delivered or withheld to pay the exercise price or tax liability.
How many Regeneron (REGN) options did the CFO exercise and at what price?
Fenimore exercised a non-qualified stock option covering 6,283 shares of Regeneron common stock at an exercise price of $381.92 per share. The award vested in four equal annual installments starting one year after the grant date.
What derivative position remains for the REGN CFO after this transaction?
After the reported option exercise, Fenimore had 6,000 non-qualified stock options remaining from this award, with an exercise price of $381.92 per share and an expiration date of 2026-12-16.
AI-generated analysis. How Rhea-AI works. Not financial advice.
